HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hoyoku Nishino Selected Research

xanthomonasin A

2/2005Azaphilones, furanoisophthalides, and amino acids from the extracts of Monascus pilosus-fermented rice (red-mold rice) and their chemopreventive effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hoyoku Nishino Research Topics

Disease

86Neoplasms (Cancer)
02/2014 - 01/2000
47Carcinogenesis
11/2013 - 01/2000
8Inflammation (Inflammations)
01/2015 - 02/2002
7Papilloma (Papillomatosis)
04/2008 - 06/2002
6Hepatocellular Carcinoma (Hepatoma)
03/2009 - 01/2004
6Osteonecrosis (Kienbock's Disease)
07/2008 - 01/2003
4Colonic Neoplasms (Colon Cancer)
06/2007 - 01/2002
3Adenocarcinoma
11/2013 - 02/2002
3Lung Neoplasms (Lung Cancer)
02/2012 - 04/2004
3Hepatitis
03/2009 - 01/2007
3Liver Neoplasms (Liver Cancer)
03/2009 - 01/2004
3Fibrosis (Cirrhosis)
03/2009 - 01/2007
2Abdominal Obesity
07/2015 - 12/2010
2Obesity
07/2015 - 12/2010
2Adenoma (Adenomas)
11/2013 - 02/2002
2Prostatic Neoplasms (Prostate Cancer)
11/2004 - 05/2003
2Cardiovascular Diseases (Cardiovascular Disease)
07/2004 - 02/2002
2Neoplasm Metastasis (Metastasis)
01/2004 - 09/2002
2Carcinoma (Carcinomatosis)
09/2002 - 02/2002
1Muscular Atrophy (Muscle Atrophy)
03/2021
1Atrophy
04/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016
1Atherosclerosis
01/2016
1Hypercholesterolemia
01/2016
1Non-alcoholic Fatty Liver Disease
12/2015
1Colorectal Neoplasms (Colorectal Cancer)
02/2014
1Polyps
02/2014
1Foreign Bodies (Foreign Body)
11/2013

Drug/Important Bio-Agent (IBA)

18Epstein-Barr virus early antigenIBA
01/2009 - 02/2002
15Carotenoids (Carotene)IBA
02/2014 - 01/2000
14anthraceneIBA
01/2009 - 02/2002
13CarcinogensIBA
09/2013 - 02/2002
10Peroxynitrous Acid (Peroxynitrite)IBA
01/2009 - 02/2002
9TriterpenesIBA
08/2007 - 03/2002
6Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2013 - 09/2002
6isoliquiritigenin (GU 17)IBA
01/2006 - 02/2002
5PhytochemicalsIBA
01/2009 - 01/2000
5SteroidsIBA
07/2008 - 12/2002
5AcidsIBA
06/2007 - 02/2002
5FlavonoidsIBA
11/2005 - 05/2003
4fucoxanthinIBA
03/2021 - 01/2002
4LactoferrinIBA
01/2016 - 12/2010
4Phosphates (Orthophosphate)IBA
09/2006 - 11/2003
4BuffersIBA
09/2006 - 11/2003
49,10-Dimethyl-1,2-benzanthraceneIBA
02/2004 - 02/2003
3TabletsIBA
07/2015 - 12/2010
3nobiletinIBA
09/2013 - 01/2004
3cucurbitaneIBA
08/2007 - 02/2002
3AlkaloidsIBA
01/2006 - 03/2002
3CoumarinsIBA
03/2005 - 02/2002
3AzoxymethaneIBA
05/2004 - 02/2002
3GlycosidesIBA
07/2003 - 02/2002
2Dexamethasone (Maxidex)FDA LinkGeneric
03/2021 - 12/2002
2CholesterolIBA
01/2016 - 02/2014
2Transcription Factors (Transcription Factor)IBA
01/2015 - 07/2003
2ZeaxanthinsIBA
02/2014 - 01/2002
2beta Carotene (Betacarotene)FDA Link
02/2014 - 01/2002
2LuteinIBA
02/2014 - 01/2002
2alpha-caroteneIBA
02/2014 - 01/2002
2Nitric Oxide Synthase (NO Synthase)IBA
11/2013 - 01/2004
2capsanthinIBA
02/2012 - 01/2002
2Pharmaceutical PreparationsIBA
02/2012 - 01/2008
2Biomarkers (Surrogate Marker)IBA
03/2010 - 11/2005
2Beta-CryptoxanthinIBA
03/2009 - 01/2002
2Proteins (Proteins, Gene)FDA Link
03/2009 - 09/2007
2Adrenal Cortex Hormones (Corticosteroids)IBA
07/2008 - 03/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2007 - 08/2005
2LigandsIBA
06/2007 - 08/2005
2Glycerol (Glycerine)FDA LinkGeneric
12/2006 - 03/2003
2Emodin (Archin)IBA
09/2006 - 08/2002
2EnzymesIBA
01/2006 - 11/2005
2RNA (Ribonucleic Acid)IBA
11/2005 - 02/2002
2LuteolinIBA
11/2005 - 08/2005
2Glycyrrhetinic Acid (Po 12)IBA
11/2005 - 02/2003
2monascinIBA
10/2005 - 02/2005
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
07/2004 - 07/2003
2deguelinIBA
06/2004 - 01/2004
2alpha-toxicarolIBA
06/2004 - 01/2004
2Dinoprostone (PGE2)FDA Link
05/2004 - 01/2004
2AntioxidantsIBA
01/2004 - 06/2002
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
11/2003 - 02/2003
2NaphthoquinonesIBA
11/2003 - 02/2003
2glycerolglycolipidsIBA
03/2003 - 12/2002
2TeaIBA
02/2003 - 04/2002
2AntigensIBA
02/2003 - 02/2002
2XanthonesIBA
02/2003 - 03/2002
2LycopeneIBA
03/2002 - 01/2002
1fucoxanthinolIBA
04/2020
1Triglycerides (Triacylglycerol)IBA
04/2020
1Glycoproteins (Glycoprotein)IBA
12/2015
1Analgesics (Analgesic Drugs)IBA
01/2015
1Messenger RNA (mRNA)IBA
01/2015
1AntipyreticsIBA
01/2015
1NF-kappa B (NF-kB)IBA
01/2015
1Caspase 3 (Caspase-3)IBA
11/2013
1pimagedine (aminoguanidine)IBA
11/2013

Therapy/Procedure

7Chemoprevention
01/2007 - 01/2000
5Oral Administration
03/2021 - 02/2003
5Therapeutics
06/2007 - 04/2004
3Kidney Transplantation
05/2007 - 11/2003